Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
Gastric cancer is one of the most common oncological diseases at the present time, so research in this area is very significant and relevant. Immunological checkpoint inhibitors have previously demonstrated their effectiveness and safety in various solid tumors, however, with regard to stomach canc...
Saved in:
| Main Authors: | T. N. Sotnikova, N. V. Danilova, P. G. Malkov, T. V. Polushkina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-07-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of programmed cell death 1 and its programmed cell death ligand 1 levels in vitiligo
by: Hanan R. Nada, et al.
Published: (2025-01-01) -
Assessment of PD-L1 expression in patients with neuroblastoma and renal tumors
by: Seher Şener, et al.
Published: (2021-10-01) -
Efficacy of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: A systematic review and meta-analysis
by: Tzu-Rong Peng, et al.
Published: (2023-11-01) -
Programmed death‐ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2‐negative status
by: Lei Wang, et al.
Published: (2018-06-01) -
Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review
by: Peifeng Chen, et al.
Published: (2025-03-01)